Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Alimera CEO Myers Shares Lessons From Iluvien FDA Approval

    Alimera CEO Myers Shares Lessons From Iluvien FDA Approval

    FromOIS Podcast | Ophthalmology's leading Podcast

    Start listeningView podcast show

    Alimera CEO Myers Shares Lessons From Iluvien FDA Approval

    FromOIS Podcast | Ophthalmology's leading Podcast

    ratings:
    Length:
    18 minutes
    Released:
    Dec 2, 2014
    Format:
    Podcast episode

    Description

    The FDA turned away Alimera Sciences’ bid to market Iluvien as a treatment for diabetic macular edema three times before finally giving the green light. President & CEO Dan Myers shares what kept his confidence up during this lengthy review and how Alimera Sciences is positioning Iluvien in the DME market.
    Released:
    Dec 2, 2014
    Format:
    Podcast episode

    Titles in the series (100)

    Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.